Dr Reddy’s Labs gets CDSCO nod for Zytorvi use in esophageal squamous cell carcinoma
Dr Reddy’s gets CDSCO approval for Zytorvi (toripalimab) with chemo as first-line treatment for advanced ESCC in adults, backed by Phase 3 data.
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"esophageal squamous cell carcinoma"